Peptidus

New drug development faces significant challenges, as the high risk of development often limits investments from veterinary medicine companies. Peptidus Biotech addresses this challenge by leveraging its AI-driven platform to reduce the risk-return ratio in veterinary drug development, making innovation in animal health more efficient and cost-effective